Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 10, 2004, Pages 3871-3876

  Markovich, Sarit ^a   Yekutiel, Aya ^a   Shalit, Itamar ^a   Shadkchan, Yona ^a   Osherov, Nir ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; CHITIN; ERGOSTEROL; FLUCONAZOLE; FLUCYTOSINE; MANNAN; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; STAUROSPORINE;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; ASPERGILLUS; CELL FUNCTION; CELL TRANSPORT; CELL VACUOLE; CELL WALL; DELETION MUTANT; DILUTION; DRUG SENSITIVITY; FUNGAL GENE; FUNGUS MUTATION; GENE MAPPING; MEMBRANE FORMATION; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANTIFUNGAL AGENTS; CELL MEMBRANE; CELL WALL; CHITIN; ENDOSOMES; ERGOSTEROL; MICROBIAL SENSITIVITY TESTS; MUTATION; OPEN READING FRAMES; ORGANISMS, GENETICALLY MODIFIED; PEPTIDES, CYCLIC; PROTEIN KINASE C; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; VACUOLES;

EID: 4644302726     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.10.3871-3876.2004     Document Type: Article

References (35)

1. Agarwal, A. K., P. D. Rogers, S. R. Baerson, M. R. Jacob, K. S. Barker, J. D. Cleary, L. A. Walker, D. G. Nagle, and A. M. Clark. 2003. Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. J. Biol. Chem. 278: 34998-35015.
2. Anderson, J. B., C. Sirjusingh, A. B. Parsons, C. Boone, C. Wickens, L. E. Cowen, and L. M. Kohn. 2003. Mode of selection and experimental evolution of antifungal drug resistance in Saccharomyces cerevisiae. Genetics 163:1287-1298.
3. Arikan, S., M. Lozano-Chiu, V. Paetznick, and J. H. Rex. 2002. In-vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. Antimicrob. Agents Chemother. 46:245-247.
4. Blackburn, A. S., and S. V. Avery. 2003. Genome-wide screening of Saccharomyces cerevisiae to identify genes required for antibiotic insusceptibility of eukaryotes. Antimicrob. Agents Chemother. 47:676-681.
5. Brachmann, C. B., A. Davies, G. J. Cost, E. Caputo, J. Li, P. Hieter, and J. D. Boeke. 1998. Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast 14:115-132.
6. Chan, T. F., J. Carvalho, L. Riles, and X. F. Zheng. 2000. A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR). Proc. Natl. Acad. Sci. USA 97:13227-13232.
7. Cheng, A. L., S. E. Chuang, R. L. Fine, K. H. Yeh, C. M. Liao, J. D. Lay, and D. S. Chen. 1998. Inhibition of the membrane translocation and activation of protein kinase C and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen. Biochem. Pharmacol. 55:523-531.
8. Davenport, K. R., M. Sohaskey, Y. Kamada, D. E. Levin, and M. C. Gustin. 1995. A second osmosensing signal transduction pathway in yeast. Hypotonic shock activates the PKC1 protein kinase-regulated cell integrity pathway. J. Biol. Chem. 270:30157-30161.
9. 1, fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. Antimicrob. Agents Chemother. 44:739-746.
10. Desmoucelles, C., B. Pinson, C. Saint-Marc, and B. Daignan-Fornier. 2002. Screening the yeast "disruptome" for mutants affecting resistance to the immunosuppressive drug, mycophenolic acid. J. Biol. Chem. 277:27036-27044.
11. Douglas, C. M. 2001. Fungal beta (1,3)-D-glucan synthesis. Med. Mycol. 39:55-66.
12. Douglas, C. M., F. Foor, J. A. Marrinan, N. Morin, J. B. Nielsen, A. M. Dahl, P. Mazur, W. Baginsky, W. Li, M. el-Sherbeini, et al. 1994. The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase. Proc. Natl. Acad. Sci. USA 91:12907-12911.
13. Douglas, C. M., J. A. Marrinan, W. Li, and M. B. Kurtz. 1994. A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-beta-D-glucan synthase. J. Bacteriol. 176:5686-5696.
14. Drgonová, J., T. Drgon, K. Tanaka, I. Kollar, G. C. Chen, R. A. Ford, C. S. Chan, Y. Takai, and E. Cabib. 1996. Rho1p, a yeast protein at the interface between cell polarization and morphogenesis. Science 272:277-279.
15. Drose, S., and K. Altendorf. 1997. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol. 200:1-8.
16. Geber, A., C. A. Hitchcock, J. E. Swartz, F. S. Pullen, K. E. Marsden, K. J. Kwon-Chung, and J. E. Bennett. 1995. Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrob. Agents Chemother. 39: 2708-2717.
17. Goekjian, P. G., and M. R. Jirousek. 2001. Protein kinase C inhibitors as novel anticancer drugs. Expert Opin. Investig. Drugs 10:2117-2140.
18. Guest, G. M., X. Lin, and M. Momany. 2004. Aspergillus nidulans RHoA is involved in polar growth, branching, and cell wall synthesis. Fungal Genet. Biol. 41:13-22.
19. Haria, M., and H. M. Bryson. 1995. Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections. Drugs 49:103-120.
20. Kelly, S. L., D. C. Lamb, A. J. Corran, B. C. Baldwin, and D. E. Kelly. 1995. Mode of action and resistance to azole antifungals associated with the formation of 14α methylergosta 8,24(28)-dien-3β6α-diol. Biochem. Biophys. Res. Commun. 207:910-915.
21. Kelly, S. L., D. C. Lamb, D. E. Kelly, N. J. Manning, J. Loeffler, H. Hebart, U. Schumacher, and H. Einsele. 1997. Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation. FEBS Lett. 400:80-82.
22. Ketela, T., R. Green, and H. Bussey. 1999. Saccharomyces cerevisiae mid2p is a potential cell wall stress sensor and upstream activator of the PKC1-MPK1 cell integrity pathway. J. Bacteriol. 181:3330-3340.
23. Kirkpatrick, W. R., S. Perea, B. J. Coco, and T. F. Patterson. 2002. Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis. Antimicrob. Agents Chemother. 46:2564-2568.
24. Klionsky, D. J., P. K. Herman, and S. D. Emr. 1990. The fungal vacuole: composition, function, and biogenesis. Microbiol. Rev. 54:266-292.
25. Kontoyiannis, D. P., and R. E. Lewis. 2003. Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far. Drug Resist. Update 6:257-269.
26. Osherov, N., G. S. May, N. D. Albert, and D. P. Kontoyiannis. 2002. Over-expression of Sbe2p, a Golgi protein, results in resistance to caspofungin in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 46:2462-2469.
27. Reinoso-Martin, C., C. Schuller, M. Schuetzer-Muehlbauer, and K. Kuchler. 2003. The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling. Eukaryot. Cell 2:1200-1210.
28. Ruiz-Herrera, J., and G. San-Blas. 2003. Chitin synthesis as target for antifungal drugs. Curr. Drug Targets Infect. Disord. 3:77-91.
29. Sekiya-Kawasaki, M., M. Abe, A. Saka, D. Watanabe, K. Kono, M. Minemura-Asakawa, S. Ishihara, T. Watanabe, and Y. Ohya. 2002. Dissection of upstream regulatory components of the Rho1p effector, 1,3-beta-glucan synthase, in Saccharomyces cerevisiae. Genetics 162:663-676.
30. Shalit, I., Y. Shadkchan, Z. Samra, and N. Osherov. 2003. In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points. Antimicrob. Agents Chemother. 47:1416-1418.
31. Silve, S., P. Leplatois, A. Josse, P. H. Dupuy, C. Lanau, M. Kaghad, C. Dhers, C. Picard, A. Rahier, M. Taton, G. Le Fur, D. Caput, P. Ferrara, and G. Loison. 1996. The immunosuppressant SR 31747 blocks cell proliferation by inhibiting a steroid isomerase in Saccharomyces cerevisiae. Mol. Cell. Biol. 16:2719-2727.
32. Winzeler, E. A., D. D. Shoemaker, A. Astromoff, H. Liang, K. Anderson, B. Andre, R. Bangham, R. Benito, J. D. Boeke, and H. Bussey. 1999. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285:901-906.
33. Yoshida, S., and Y. Anraku. 2000. Characterization of staurosporine-sensitive mutants of Saccharomyces cerevisiae: vacuolar functions affect staurosporine sensitivity. Mol. Gen. Genet. 263:877-888.
34. Zewail, A., M. W. Xie, Y. Xing, L. Lin, P. F. Zhang, W. Zou, J. P. Saxe, and J. Huang. 2003. Novel functions of the phosphatidylinositol metabolic pathway discovered by a chemical genomics screen with wortmannin. Proc. Natl. Acad. Sci. USA 100:3345-3350.
35. Zhao, C., U. S. Jung, P. Garrett-Engele, T. Roe, M. S. Cyert, and D. E. Levin. 1998. Temperature-induced expression of yeast FKS2 is under the dual control of protein kinase C and calcineurin. Mol. Cell. Biol. 18:1013-1022.